Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer

National Cancer Center, Korea134 enrolled

Overview

* Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively * Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics

Patients with primary ovarian cancer * Informed consent * Digital photography \& Checking PCI (tumor size, number, and Characteristics) * Postoperative surveillance(tumor marker, image and physical examination) 1. Developing the best fitting PCI model to reflect recurrence-free survival and overall survival * Selection of items * Weighting by items and tumor characteristics 2. Analysis of prognostic impact of PCI compared to conventional staging system (FIGO stage) for ovarian cancer

Study Type

OBSERVATIONAL

Enrollment

134

Conditions

Ovarian Cancer

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: 1. Preoperative clinical diagnosis of ovarian cancer, tubal cancer, and primary peritoneal carcinoma (all stage) 2. Available preoperative image study (CT and/or MRI and/or PET) 3. Patients who gave a written informed consent 4. Patients must be surgical candidate considering medical and psychological condition Exclusion Criteria: * Patients who refuse to participate or want to withdraw at anytime.

Locations (1)

National Cancer Center

Goyang-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Devleopment for the peritoneal carcinomatosis index (PCI)

Time frame: 55 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.